Dél-afrikai Köztársaság - angol - South African Health Products Regulatory Authority (SAHPRA)

abbott laboratories s.a. (pty) ltd - tablet - see ingredients - each tablet contains hyperici herba extractum siccum equivalent to 0,5 mg total hypericin

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - cyproterone acetate -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - cyproterone acetate -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - sirolimus -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - vemurafenib -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

metagenics (aust) pty ltd - hypericum perforatum -

Izrael - angol - Ministry of Health

tzamal bio-pharma ltd - 5-aminolevulinic acid as hydrochloride - powder for solution - 5-aminolevulinic acid as hydrochloride 1.5 g - aminolevulinic acid - aminolevulinic acid - gliolan® is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (who grade iii and iv).

Izrael - angol - Ministry of Health

roche pharmaceuticals (israel) ltd - vemurafenib - film coated tablets - vemurafenib 240 mg - vemurafenib - vemurafenib - zelboraf is indicated for the treatment of brafv600 mutation-positive unresectable or metastatic melanoma.

Európai Unió - angol - EMA (European Medicines Agency)

roche registration gmbh - vemurafenib - melanoma - antineoplastic agents - vemurafenib is indicated in monotherapy for the treatment of adult patients with braf-v600-mutation-positive unresectable or metastatic melanoma.,